Official Action indicated for one of their core facilities in Montreal. Hope it’s not a repeat of what happened to their Roorkee plant where management failed to address audit findings flagging official action. This led to ban on the Roorkee facility and it took Jubilant 2 years to get that lifted.
Company clearly stands to benefit from several industry tailwinds (including Biosecure act) but USFDA inspection is always an overhang for the stock.
Disc- Invested
| Subscribe To Our Free Newsletter |
